Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 20,000,000
    Countries
    Sector(s)
    France : € 20,000,000
    Industry : € 20,000,000
    Signature date(s)
    30/07/2024 : € 20,000,000
    Link to source

    Summary sheet

    Release date
    1 August 2024
    Status
    Reference
    Signed | 30/07/2024
    20230781
    Project name
    Promoter - financial intermediary
    FABENTECH (IEU TI HERA)
    FABENTECH SA
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 20 million
    EUR 55 million
    Location
    Sector(s)
    Description
    Objectives

    The operation will finance the promoter's research, development and innovation (RDI) investments related to the manufacturing of novel polyclonal antibodies against potential biothreats and emerging diseases. More specifically, the loan will support the part of the project concerning pandemic preparedness and industrial improvements (Nipah virus with pandemic potential and other costs).

    The aim is to enable Fabentech to accelerate its RDI to develop emergency treatments against toxins and pathogens with pandemic/epidemic potential.

    Additionality and Impact

    The project is aligned with the InvestEU objective of promoting research, development, and innovation. The purpose of the loan is to provide direct equity-type financing under INVESTEU, benefiting from the EC guarantee, to finance research and development activities of innovative biotech companies. In addition, the operation falls under the eligibility criteria (i) "Pathogens with pandemic or epidemic potential" and (ii) "Chemical, biological, radiological and nuclear (CBRN) threats originating from accidental or deliberate release" of article 3.2 of the HERA Invest Top-Up Annex.

     

    The project, if successful, is expected to have significant financial and broader social benefits, in terms of the availability of treatments to counteract viruses with pandemic potential and biothreats. R&D and manufacturing are conducted in Europe, securing supplies for Europe. By supporting the promoter, the EIB enables the generation of European scientific knowledge and acumen and increasing highly skilled employment opportunities.


    The financing of this project addresses the failure in financial markets for RDI-driven European SMEs suffering from systemic shortages of financing options for growth investments. Currently, the Company has limited access to financing sources from traditional or alternative debt providers. The financing structure is adjusted to the investment needs of the Company and provides a long tenor. By contributing to extending the cash runway and therefore to de-risking the development plan of the company, the EIB financing is expected to crowd-in third party investors and allow the company to accelerate its development. The project would not have been carried out (to the same extent) by the EIB without the InvestEU support.

    Environmental aspects
    Procurement

    The promoter's investments concern research, development and innovation activities that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during appraisal.

    The promoter is a private company, not operating in the utilities sector and does not have the status of a contracting authority; thus the project is not covered by the EU directives on procurement. However, the promoter's procurement procedures are expected to be in line with EIB guidelines for private sector projects. Further details will be assessed during the project due diligence.

    Milestone
    Under appraisal
    Approved
    Signed
    17 July 2024
    30 July 2024
    Related projects
    Link to source

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - FABENTECH (IEU TI HERA)
    Publication Date
    14 Aug 2024
    Document language
    Main Topic
    Lending
    Document Number
    190745378
    Document Focus
    Environmental Information
    Project Number
    20230781
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now

    News & Stories

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

    Related publications